CSL Ltd

Skip to main content

Company

CSL Ltd

53 results

Future of HealthcategoryPfizer's hemophilia therapy reduces bleeding in late-stage studyMay 30, 2023
BusinesscategoryVertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review groupApril 12, 2023
Healthcare & PharmaceuticalscategoryVaccine makers prep bird flu shot for humans 'just in case'; rich nations lock in suppliesMarch 20, 2023
BusinesscategorySarepta slides as FDA about-turn on panel clouds gene therapy approval pathMarch 17, 2023
Healthcare & PharmaceuticalscategoryFlu experts gather with H5N1 risk on the agendaFebruary 24, 2023
Healthcare & PharmaceuticalscategoryU.S. new drug price exceeds $200,000 median in 2022January 5, 2023
Healthcare & PharmaceuticalscategoryEU regulator backs gene therapy to treat rare bleeding disorderDecember 16, 2022
BusinesscategoryAustralia's CSL prices hemophilia gene therapy at $3.5 millionNovember 22, 2022
BusinesscategoryU.S. flu hospitalizations highest in 10 years, officials sayNovember 4, 2022
BusinesscategoryAustralia's CSL in mRNA vaccine licensing deal with U.S.-based ArcturusNovember 1, 2022
BusinesscategoryAustralia's CSL raises annual profit forecast on Swiss acquisitionOctober 17, 2022
BusinesscategoryAustralia biotech giant CSL reports profit dip, flags cost spiralAugust 17, 2022
BusinesscategoryKKR-led group offers record $14.8 bln bid for Australia's Ramsay HealthApril 20, 2022
BusinesscategoryAustralia biotech firm CSL says plasma business hit by Omicron, but demand robustFebruary 16, 2022
MarketscategoryAustralia shares rise as Russia-Ukraine tensions easeFebruary 16, 2022
MarketscategoryCSL, energy stocks drag Australia shares lower; tech rally limits lossesDecember 16, 2021
MarketscategoryCSL drags Australian shares lower, tech stocks riseDecember 16, 2021
MarketscategoryDeals of the day Mergers and acquisitionsDecember 14, 2021
MarketscategoryEuropean shares fall again with cenbank meetings in focusDecember 14, 2021
MarketscategoryAustralia's CSL to buy Swiss drugmaker Vifor for $11.7 blnDecember 14, 2021

1 to 20 of 53